Cancer Diagnostics Device Market Driven By Demand for personalized medicines

0
25
Cancer Diagnostics Device Market
Cancer Diagnostics Device Market

The global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.

An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options.

The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor.

Covered in this report
The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio’s report, Global Cancer Diagnostics Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
Abbott Diagnostics
Agilent Technologies
BD
bioMrieux
Qiagen
Roche Diagnostics

Get the Sample Copy Of This Report : https://www.marketresearchreports.biz/sample/sample/741826

Other prominent vendors 
Affymetrix
Ambry Genetics
Annoroad
Aviva Biosciences
Biochain
Bio-Rad
Cancer Genetics
Cepheid
CompanionDx
DiagnoCure
Epic Sciences
Epigenomics
Genomic Health
HalioDX
Hologic
Illumina
Myriad Genetics
Thermo Fisher Scientific
Ventana Medical Systems
Vysis

Market driver 
Demand for personalized medicines
For a full, detailed list, view our report

Market challenge
High cost of developing companion diagnostics
For a full, detailed list, view our report

Market trend 
Demand for personalized medicines
For a full, detailed list, view our report

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Leave a Reply